From its foundations in Egypt to an expanding international footprint, MEVAC has grown into a trusted global partner in animal health, delivering innovative vaccine solutions to customers across more than 50 countries spanning four continents. Our continued investment in scientific excellence, advanced manufacturing, and strong local partnerships enables us to support veterinarians, producers, and animal health professionals in diverse markets worldwide.
Today, MEVAC products are trusted across the Middle East, Asia, Africa, the CIS region and Latin America. The company continues to expand its international reach through innovation, strategic partnerships, and world-class manufacturing capabilities.
MEVAC’s global presence is driven by innovative animal health solutions and vaccines developed using the most up-to-date strains to address evolving disease challenges across diverse markets.
International markets are a key driver of MEVAC’s success, with export markets contributing more than 65% of the company’s total sales revenue. This strong export performance reflects the confidence customers worldwide place in MEVAC’s vaccine quality, scientific expertise, and reliable supply capabilities.
The recent expansion into Brazil marks another important milestone in MEVAC’s international growth journey and reinforces MEVAC’s ambition to become one of the world’s most trusted providers of animal health vaccines and solutions.
The home market and global manufacturing hub of MEVAC.
A strategic market supporting poultry and livestock development.
Strong presence across Kazakhstan, Uzbekistan, Azerbaijan, and Georgia.
Remarkable presence in Thailand, Malaysia, Philippines, Nepal, Sri Lanka and Vietnam.
An important growth region with expanding market opportunities.
A growing region where MEVAC continues to strengthen its presence.
The newest strategic milestone in one of the largest poultry and livestock markets globally.
MEVAC is actively pursuing the next phase of growth in Europe through expanded registrations, stronger partnerships, and enhanced market access initiatives. Building on its established presence, the company aims to introduce additional innovative vaccine technologies while meeting the highest international quality and regulatory standards.
Serving markets worldwide across 4 continents.
More than 65% of annual sales revenue is generated from export markets.
Strong presence in Egypt, Middle East, Pakistan, Asia, Europe, CIS, Africa, and Latin America.
A new market entry supporting future growth across Latin America.
Long-term vision to expand into more than 90 countries.
